Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martin Allan is active.

Publication


Featured researches published by Martin Allan.


Bioorganic & Medicinal Chemistry Letters | 2009

N-Benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1).

Martin Allan; Sukhdev Manku; Eric Therrien; Natalie Nguyen; Sylvia Styhler; Marie-France Robert; Anne-Christine Goulet; Andrea J. Petschner; Gabi Rahil; A. Robert MacLeod; Robert Deziel; Jeffrey M. Besterman; Hannah Nguyen; Amal Wahhab

A series of N-benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides targeting co-activator associated arginine methyltransferase 1 (CARM1) have been designed and synthesized. The potency of these inhibitors was influenced by the nature of the heteroaryl fragment with the thiophene analogues being superior to thiazole, pyridine, isoindoline and benzofuran based inhibitors.


Bioorganic & Medicinal Chemistry Letters | 2009

1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1).

Eric Therrien; Guillaume Larouche; Sukhdev Manku; Martin Allan; Natalie Nguyen; Sylvia Styhler; Marie-France Robert; Anne-Christine Goulet; Jeffrey M. Besterman; Hannah Nguyen; Amal Wahhab

We have identified the N(1)-benzyl-N(2)-methylethane-1,2-diamine unit as a substitute for the (S)-alanine benzylamide moiety for the design of co-activator associated arginine methyltransferase 1 (CARM1) inhibitors. The potency of these inhibitors is in the same order of magnitude as their predecessors and their clearance, volume of distribution, and half lives were greatly improved.


Bioorganic & Medicinal Chemistry Letters | 2009

Sulfamides as novel histone deacetylase inhibitors

Amal Wahhab; David Smil; Alain Ajamian; Martin Allan; Yves Andre Chantigny; Eric Therrien; Natalie Nguyen; Sukhdev Manku; Silvana Leit; Jubrail Rahil; Andrea J. Petschner; Aihua Lu; Alina Nicolescu; Sylvain Lefebvre; Samuel Montcalm; Marielle Fournel; Theresa P. Yan; Zuomei Li; Jeffrey M. Besterman; Robert Deziel

The sulfamide moiety has been utilized to design novel HDAC inhibitors. The potency and selectivity of these inhibitors were influenced both by the nature of the scaffold, and the capping group. Linear long-chain-based analogs were primarily HDAC6-selective, while analogs based on the lysine scaffold resulted in potent HDAC1 and HDAC6 inhibitors.


Bioorganic & Medicinal Chemistry Letters | 2009

Synthesis and evaluation of lysine derived sulfamides as histone deacetylase inhibitors

Sukhdev Manku; Martin Allan; Natalie Nguyen; Alain Ajamian; Jacques Rodrigue; Eric Therrien; James C. Wang; Tim Guo; Jubrail Rahil; Andrea J. Petschner; Alina Nicolescu; Sylvain Lefebvre; Zuomei Li; Marielle Fournel; Jeffrey M. Besterman; Robert Deziel; Amal Wahhab

We have recently reported on a novel class of histone deacetylase (HDAC) inhibitors bearing a sulfamide group as the zinc-binding unit. Herein, we report on the synthesis of sulfamide based inhibitors designed around a lysine scaffold and their structure-activity relationships against HDAC1 and HDAC6 isotypes as well as 293T cells. Our efforts led us to an improvement of the originally disclosed lysine-based sulfamide, 2a to compound 12h which has equal potency in enzyme and cell-based assays as well as enhanced metabolic stability and PK profile.


Journal of Medicinal Chemistry | 2002

Structurally simple trichostatin A-like straight chain hydroxamates as potent histone deacetylase inhibitors.

Soon Hyung Woo; Sylvie Frechette; Elie Abou Khalil; Giliane Bouchain; Arkadii Vaisburg; Naomy Bernstein; Oscar Moradei; Silvana Leit; Martin Allan; Marielle Fournel; Marie-Claude Trachy-Bourget; Zuomei Li; Jeffrey M. Besterman; Daniel Delorme


Archive | 2008

Small molecule inhibitors of protein arginine methyltransferases (prmts)

Amal Wahhab; Eric Therrien; Martin Allan; Sukhdev Manku


Archive | 2006

Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase

Silvana Leit; Amal Wahhab; Martin Allan; David Smil; Pierre Tessier; Robert Deziel; Yves Andre Chantigny


Bioorganic & Medicinal Chemistry Letters | 2004

(2-Amino-phenyl)-amides of ω-substituted alkanoic acids as new histone deacetylase inhibitors

Arkadii Vaisburg; Naomy Bernstein; Sylvie Frechette; Martin Allan; Elie Abou-Khalil; Silvana Leit; Oscar Moradei; Giliane Bouchain; James Wang; Soon Hyung Woo; Marielle Fournel; Pu T. Yan; Marie-Claude Trachy-Bourget; Ann Kalita; Carole Beaulieu; Zuomei Li; A. Robert MacLeod; Jeffrey M. Besterman; Daniel Delorme


Archive | 2008

Amines as Small Molecule Inhibitors

Amal Wahhab; Eric Therrien; Martin Allan; Sukhdev Manku


Archive | 2007

Sulfamide and sulfamate derivatives as histone deacetylase inhibitors

David Smil; Silvana Leit; Alain Ajamian; Martin Allan; Yves Andre Chantigny; Robert Deziel; Eric Therrien; Amal Wahhab; Sukhdev Manku

Collaboration


Dive into the Martin Allan's collaboration.

Top Co-Authors

Avatar

Eric Therrien

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Silvana Leit

Facultad de Ciencias Exactas y Naturales

View shared research outputs
Top Co-Authors

Avatar

Zuomei Li

Vanderbilt University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge